Elevance Health Inc. (ELV) Stock Overview
Explore Elevance Health Inc.’s financial performance, market position, analyst ratings, and future outlook.
Elevance Health Inc. (ELV)
Key Financials
Key Financials
Market Cap
89.9B
P/E Ratio
18.39
EPS (TTM)
$29.39
ROE
0.11%
ELV Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of Elevance Health Inc. (NYSE: ELV) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, Elevance Health Inc.'s NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of ELV on the NYSE shows an RSI of 63.10, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $357.71 for the NYSE listing.
Key metrics behind Elevance Health Inc.'s NYSE-traded stock include a P/E ratio of 18.39 and a market capitalization of 89.9B. Combined with our AI analysis, these give both institutional and retail investors a clear view of ELV on the NYSE.